Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ruboxistaurin mesilate may improve symptoms of diabetic peripheral neuropathy

May 21, 2004

New glucokinase activators covered by Roche patent

May 20, 2004

Roche scientists identify new PPARalpha/PPARgamma agonists

May 20, 2004

Dual PPARalpha/PPARgamma agonists and their use claimed by Merck KGaA

May 20, 2004

Fournier presents new hypoglycemic and hypolipidemic agents

May 20, 2004

Olpadronate increases bone strength in mice

May 20, 2004

Cinacalcet controls parathyroid hormone in kidney disease patients

May 20, 2004

Chemokine Therapeutics submits IND for CTCE-0214

May 20, 2004

Aventis ends agreement with DeveloGen for DiaPep277

May 20, 2004

Potassium channel modulation blocks insulin release

May 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...